What to read around the web today

• In race for Covid-19 vaccine, China tries for a coup (Wall Street Journal)
• BeiGene’s newly-approved Brukinsa will be “highly affordable” for Chinese patients (The Pharma Letter)
• Watch: Chi-Med gets U.S. fast-track for tumor treatment drug surufatinib, says CEO (CNBC)
• Hong Kong biotech IPO outlook positive amid heightened market volatility (S&P Global)